Physician

Christopher Thad Scholes, M.D.

According to 2025 Medicare claims, Christopher Scholes, M.D. (NPI: 1760491542) practices dermatology in the Twin Falls, ID market, with the plurality of this provider's patient population coming from Twin Falls, ID. This provider's primary affiliated billing organization is SCHOLES DERMATOLOGY LLC (NPI: 1366810442; TIN: 464353030) and primary practice location at 83301-5050.

Scholes' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 686 traditional Medicare patients, billed 6,094 HCPCS/CPT codes, and received $164,749 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 680 prescription claims across 269 beneficiaries totaling $363,330 in drug costs, led by Humira(Cf) (Adalimumab). Open Payments data shows 21 records totaling $360. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $209,086 to $363,330. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,051	9,253	$195,200
2016	1,021	8,954	$210,489
2017	941	8,584	$206,507
2018	927	8,417	$190,944
2019	938	9,022	$225,141
2020	822	6,834	$177,673
2021	823	6,647	$164,776
2022	757	6,111	$154,477
2023	725	6,368	$159,395
2024	686	6,094	$164,749

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	269	696	$209,086
2016	258	779	$260,665
2017	247	659	$316,916
2018	250	668	$321,280
2019	251	616	$161,059
2020	244	603	$219,863
2021	243	569	$314,338
2022	264	658	$402,410
2023	231	604	$471,271
2024	269	680	$363,330

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	317	466	$60
17000	Destruction of precancer skin growth, 1 growth	424	669	$39
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	317	431	$34
88305	Pathology examination of tissue using a microscope, intermediate complexity	292	509	$28
17003	Destruction of precancer skin growth, 2-14 growths	372	3,234	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf)	Adalimumab	14	392	$100,049
Cosentyx Sensoready (2 Pens)	Secukinumab	13	364	$99,977
Fluorouracil	Fluorouracil	29	734	$3,500
Calcipotriene	Calcipotriene	24	740	$2,944
Pimecrolimus	Pimecrolimus	20	635	$2,219

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$360	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher Thad Scholes, M.D.?

Tedicare shows public-source Medicare data for Christopher Thad Scholes, M.D. (NPI 1760491542), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Thad Scholes, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Christopher Thad Scholes, M.D.?

Christopher Thad Scholes, M.D. is linked to SCHOLES DERMATOLOGY LLC (billing NPI 1366810442) in the available physician profile data.

Does Christopher Thad Scholes, M.D. have Open Payments data?

Christopher Thad Scholes, M.D. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.